Efficacy but side effects of anakinra therapy for chronic refractory gout in a renal transplant recipient with preterminal chronic renal failure

Joint Bone Spine. 2012 Dec;79(6):631. doi: 10.1016/j.jbspin.2012.04.009. Epub 2012 Jul 26.

Authors

Guillaume Direz, Natacha Noël, Charlotte Guyot, Olivier Toupance, Jean-Hugues Salmon, Jean-Paul Eschard

PMID: 22841588
DOI: 10.1016/j.jbspin.2012.04.009

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Aged
Antirheumatic Agents / adverse effects
Antirheumatic Agents / pharmacology
Antirheumatic Agents / therapeutic use
Chronic Disease
Female
Gout / drug therapy*
Graft Rejection / complications
Humans
Interleukin 1 Receptor Antagonist Protein / adverse effects*
Interleukin 1 Receptor Antagonist Protein / pharmacology
Interleukin 1 Receptor Antagonist Protein / therapeutic use*
Kidney / drug effects
Kidney / physiopathology
Kidney Failure, Chronic / complications*
Kidney Transplantation*
Neutropenia / chemically induced
Neutropenia / diagnosis
Receptors, Interleukin-1 / antagonists & inhibitors
Treatment Outcome

Substances

Antirheumatic Agents
Interleukin 1 Receptor Antagonist Protein
Receptors, Interleukin-1